PMV
PMV Pharmaceuticals Inc宣布,公司计划在2027年第一季度向监管机构提交其候选药物Rezatapopt的新药申请(NDA),该药物用于治疗铂类耐药或难治性卵巢癌患者。
时间:2025-09-10 19:09:15 市场: 美股 综合
PMV Pharmaceuticals公布了其药物Rezatapopt单一疗法在Pynnacle 2期试验中的积极中期数据,该试验针对携带TP53 Y220C突变的多种实体瘤患者。
时间:2025-09-10 19:01:21 市场: 美股 综合
Premier Investments Ltd : Citi Lifts Price Target to a$26.00 From a$22.74
时间:2025-02-03 05:01:11 市场: 综合
Premier Investments Ltd Sees Premier Retail's Underlying EBIT to Be in Range of a$160 Mln to a$165 Mln in Hy
时间:2025-01-13 06:36:13 市场: 综合
Premier Investments - Key Trading Events Sales yet to Occur and Remain Critical to Company's First-Half FY2025 Results.
时间:2024-12-17 07:30:09 市场: 综合
PMV Pharmaceuticals Inc Files for Mixed Shelf of up to $200 Mln – SEC Filing
时间:2024-11-20 21:03:19 市场: 美股 综合
PMV : Oppenheimer Raises to Outperform From Perform
时间:2024-11-08 21:08:55 市场: 美股 综合
Myer Holdings Shares Rise 3.1% to Hit Highest Since March, 2023 After Deal to Acquire Premier's Apparel Business for $569 Mln
时间:2024-10-29 07:05:56 市场: 综合
Premier Investments - Myer Board Will Declare Before Completion Fully Franked Dividend of 2.5 AU Cents per Share to Existing Myer Shareholders
时间:2024-10-29 05:38:02 市场: 综合
Premier Investments - Myer Will Issue 890.5 Mln New, Fully Paid Ordinary Shares in Myer to Premier Upon Completion in Consideration for Just Group
时间:2024-10-29 05:38:02 市场: 综合